CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE

CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE was reported 37 times

CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAPSULE PHYSICAL ISSUE 1 0.0069
1 MENTAL RETARDATION 1 0.0028
2 SKIN NEOPLASM EXCISION 1 0.0013
3 APPLICATION SITE INFLAMMATION 1 0.0007
4 CHORIORETINOPATHY 1 0.0007
5 ANTICHOLINERGIC SYNDROME 1 0.0006
6 SPINAL CORD DISORDER 1 0.0006
7 SLEEP TALKING 1 0.0006
8 PRODUCT TAMPERING 1 0.0006
9 APPLICATION SITE DISCOMFORT 1 0.0006
10 BREAKTHROUGH PAIN 1 0.0004
11 VARICELLA 1 0.0004
12 RENAL FUNCTION TEST ABNORMAL 1 0.0002
13 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
14 FAECALOMA 1 0.0002
15 SOMNAMBULISM 1 0.0002
16 MUSCLE STRAIN 1 0.0001
17 HIDRADENITIS 1 0.0001
18 AUTOIMMUNE DISORDER 1 0.0001
19 COELIAC DISEASE 1 0.0001
20 LIGAMENT SPRAIN 1 0.0001
21 TEMPERATURE INTOLERANCE 1 0.0001
22 LIVER INJURY 2 0.0001
23 SMALL INTESTINAL OBSTRUCTION 1 0.0001
24 PARAESTHESIA ORAL 1 0.0001
25 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
26 TYPE 2 DIABETES MELLITUS 2 0.0001
27 END STAGE RENAL DISEASE 1 0.0001
28 POST PROCEDURAL COMPLICATION 1 0.0001
29 DRUG PRESCRIBING ERROR 1 0.0001
30 EAR PAIN 1 0.0001
31 SINUS DISORDER 1 0.0001
32 FEEDING DISORDER 1 0.0000
33 KNEE ARTHROPLASTY 1 0.0000
34 SKIN CANCER 1 0.0000
35 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
36 APPLICATION SITE PAIN 1 0.0000
37 DIPLOPIA 1 0.0000
38 APPLICATION SITE ERYTHEMA 1 0.0000
39 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
40 EXPOSURE DURING PREGNANCY 2 0.0000
41 HEAD INJURY 1 0.0000
42 HIP FRACTURE 1 0.0000
43 SKIN DISORDER 1 0.0000
44 URINARY RETENTION 1 0.0000
45 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
46 ABORTION SPONTANEOUS 1 0.0000
47 OSTEOARTHRITIS 1 0.0000
48 COLITIS ULCERATIVE 1 0.0000
49 OROPHARYNGEAL PAIN 2 0.0000
50 COGNITIVE DISORDER 1 0.0000
51 PANCREATITIS 1 0.0000
52 DISTURBANCE IN ATTENTION 1 0.0000
53 FEELING ABNORMAL 4 0.0000
54 OEDEMA PERIPHERAL 2 0.0000
55 AMNESIA 1 0.0000
56 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
57 RESPIRATORY FAILURE 1 0.0000
58 HOT FLUSH 1 0.0000
59 UNEVALUABLE EVENT 1 0.0000
60 CHRONIC KIDNEY DISEASE 1 0.0000
61 DIABETES MELLITUS 1 0.0000
62 DRUG INTERACTION 2 0.0000
63 INJECTION SITE HAEMORRHAGE 1 0.0000
64 INFLUENZA LIKE ILLNESS 1 0.0000
65 DIZZINESS 6 0.0000
66 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
67 GASTROINTESTINAL DISORDER 1 0.0000
68 ATRIAL FIBRILLATION 1 0.0000
69 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
70 CONSTIPATION 2 0.0000
71 FALL 3 0.0000
72 PALPITATIONS 1 0.0000
73 JOINT SWELLING 1 0.0000
74 VISUAL IMPAIRMENT 1 0.0000
75 PSORIASIS 1 0.0000
76 ACUTE KIDNEY INJURY 1 0.0000
77 HOSPITALISATION 1 0.0000
78 NAUSEA 5 0.0000
79 CONFUSIONAL STATE 1 0.0000
80 ABDOMINAL DISCOMFORT 1 0.0000
81 ANAEMIA 1 0.0000
82 GAIT DISTURBANCE 1 0.0000
83 ABDOMINAL PAIN UPPER 1 0.0000
84 HYPERTENSION 1 0.0000
85 MALAISE 2 0.0000
86 INCORRECT DOSE ADMINISTERED 1 0.0000
87 ABDOMINAL PAIN 1 0.0000
88 VOMITING 2 0.0000
89 FATIGUE 3 0.0000
90 WEIGHT DECREASED 1 0.0000
91 COUGH 1 0.0000
92 DYSPNOEA 2 0.0000
93 ANXIETY 1 0.0000
94 CONDITION AGGRAVATED 1 0.0000
95 INJECTION SITE PAIN 1 0.0000
96 DIARRHOEA 2 0.0000
97 PRURITUS 1 0.0000
98 ARTHRALGIA 1 0.0000
99 OFF LABEL USE 2 0.0000
100 HEADACHE 1 0.0000